Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
BACKGROUND
Postoperative fungal spondylodiscitis is a rare infectious disease.


OBJECTIVE
We report the first case of postoperative spondylodiscitis because of Scedosporium prolificans and review postoperative vertebral infection caused by fungi.


METHODS
Medline search.


METHODS
Case report and literature review.


RESULTS
On reviewing the cases of postoperative fungal spondylodiscitis reported so far in the literature, we found eight were caused by mold, and five by yeast. Clinically, the disease presents similar to postoperative vertebral osteomyelitis caused by bacteria, and a high clinical index of suspicion may be required to perform appropriate cultures to establish a diagnosis. Our review revealed a significant number of cases that were cured after surgical debridement and/or antifungal therapy.


CONCLUSIONS
On the basis of this limited assessment, it appears that the clinical course and prognosis of postoperative fungal spondylodiscitis is similar to that reported for postoperative pyogenic spondylodiscitis.
Garcia-Vidal
Carolina
C
Infectious Disease Service, IDIBELL-Hospital Universitary de Bellvitge, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. carolgv75@hotmail.com
Cabellos
Carmen
C
Ayats
Josefina
J
Font
Frederic
F
Ferran
Enrique
E
Fernandez-Viladrich
Pedro
P
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001174:Arthrodesis; D003646:Debridement; D015299:Discitis / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000601:surgery; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology / Q000382:microbiology* / Q000473:pathology; D019637:Orthopedic Procedures / Q000009:adverse effects; D011183:Postoperative Complications / Q000382:microbiology*; D011743:Pyrimidines / Q000627:therapeutic use; D021681:Scedosporium; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole